Healing Spinal Cord Lesions
There is only one category of people who can set boundaries to science: scientists ~ Rita Levi Montalcini
Hemera is a spin-off of the University of Verona and of the University of Milan, specialized in regenerative medicine for neurological diseases.
Hemera came into existence thanks to the incredibly encouraging results of preclinical studies in vitro and in vivo, with the goal of significantly improve the prospect and the quality of life of patients with acute spinal cord lesion.
We want to give back a possibility of autonomy to the patient with spinal cord trauma.
Hemera’s therapy uses a particular cell type, autologous immune cells educated in vitro to best express their pro-regenerative capacity even in a hostile microenvironment such as that of spinal cord.
To Social Investor, Venture Capitalist, and Philanthropists who want to support us
Become an investor
Diseases and accidents can leave a permanent mark on our life when there is not a cure. Hemera’s goal is to transform scientific discoveries in effective treatments and to bring research findings to the patient bedside as soon as possible.
We support the development of our cell therapy through an innovative form of widespread funding, aimed at raising the required capital from anyone who is interested in the development of new therapies for very disabling diseases and is looking for a truly socially responsible investment.
News and events
Stay informed on Hemera’s activities, follow the updates, the press review, the news, and the events in the dedicated section.
Interview with Cristiana Vignoli, protagonist of the month on Il CUBo
Cristiana Vignoli, CEO of Hemera is the protagonist of the month for February in the online magazine Cubo. In the beautiful interview by Luca...
Our 2022, step by step
We close a very intense year that marked significant steps forward in the development of the first cellular therapy for the treatment of acute...
Hemera concludes the 6th capital increase
Fundrasing results to date. On December 15, 2022, Hemera concludes the 6th capital increase. More than 2 million euros were raised in 18 months of...
Stay informed on Hemera’s latest activities with our Newsletter.